Ebit Alterar Data
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Alaunos Therapeutics USD -952K 60K 2026-06
Avita Medical AUD -6.17M 4.22M 2026-06
Celltrion KRW 20.08B 6.67B 2026-06
Cspc Pharmaceutical CNY 206.26M 1.02B 2025-12
Deva Holding AS TRY 820.88M 192.13M 2023-09
Dianthus Therapeutics USD -61.48M 14.95M 2026-06
Divis Laboratories Ltd INR 11.29B 3.15B 2026-06
IQVIA Holdings USD 608M 1.99B 2026-09
Kangmei Pharma CNY -35.26M 22.54M 2026-06
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Malin Corporation EUR -1.1M 300K 2024-12
Medical Developments International AUD -36K 12.96M 2025-12
Moderna USD -815M 573M 2026-06
Neuren Pharmaceuticals AUD 17.01M 154.09M 2025-12
Organigram Holdings CAD 5.33M 15.12M 2026-06
Organon & Co USD 377M 86M 2026-09
Ovoca Bio EUR -173K 990K 2025-12
Pharma Mar EUR 7.65M 9.06M 2026-09
Qiagen NV USD 141.4M 44.52M 2026-06
Revvity USD 126.14M 43.36M 2026-06
Sartorius EUR 179.8M 15.8M 2026-09
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Tectonic Therapeutic USD -24.22M 3.08M 2026-06
Tilray USD -20.01M 9.34M 2025-09
Viatris USD 73.7M 93.9M 2026-06
Xeris Pharmaceuticals USD -24.15M 33.27M 2026-06
Zealand Pharma A/S -389M 318.05M 2026-03
Zz Pientze Pharmaceu CNY 222.81M 140.02M 2026-09